Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

News >

FDA Approval Sought for Luspatercept for Anemias

Gina Columbus @ginacolumbusonc
Published: Friday, Apr 05, 2019

Jay Backstrom, MD

Jay Backstrom, MD

A supplemental biologics license application (sBLA) has been submitted to the FDA for luspatercept for the treatment of adult patients with very low- to intermediate-risk myelodysplastic syndrome (MDS)–associated anemia with ring sideroblasts who require red blood cell (RBC) transfusions, and also for adult patients with beta-thalassemia–associated anemia who require such transfusions.1
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication